MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

MDT

83.87

+0.59%↑

VEEV

220.35

+2.08%↑

A

105.08

+2.22%↑

WBA

10.98

0%↓

CHE

587.63

+1.41%↑

Search

Kala Pharmaceuticals Inc

Closed

3.05 5.54

Overview

Share price change

24h

Current

Min

2.89

Max

3.3

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+410.2% upside

Dividends

By Dow Jones

Next Earnings

12 May 2025

Kala Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

23 Apr 2025, 23:54 UTC

Hot Stocks

Stocks to Watch: International Business Machines, Southwest Airlines, Robert Half

23 Apr 2025, 23:23 UTC

Top News
Earnings

SK Hynix Posts Strong First Quarter Earnings on AI Chip Demand

23 Apr 2025, 21:06 UTC

Earnings

Lam Research Notches Higher 3Q Profit and Revenue, Optimistic 4Q Outlook

23 Apr 2025, 21:03 UTC

Earnings

Texas Instruments Posts Increase in 1Q Sales, EPS

23 Apr 2025, 23:47 UTC

Market Talk

Gold Rises Amid Lingering Uncertainty Over U.S.-China Trade War -- Market Talk

23 Apr 2025, 23:44 UTC

Market Talk

Nikkei May Rise as Fears About U.S. Tariffs Ease -- Market Talk

23 Apr 2025, 23:44 UTC

Market Talk

Global Equities Roundup: Market Talk

23 Apr 2025, 23:37 UTC

Market Talk

Global Energy Roundup: Market Talk

23 Apr 2025, 23:36 UTC

Market Talk

Fed Should Have a 'High Bar' to Intervene in Markets, Hammack Says -- Market Talk

23 Apr 2025, 23:21 UTC

Market Talk

Northern Star Bull Says Share Price Accounts for Operational Risks -- Market Talk

23 Apr 2025, 22:51 UTC

Earnings

SK Hynix 1Q Net Profit Beat FactSet-Compiled Consensus

23 Apr 2025, 22:50 UTC

Earnings

SK Hynix 1Q Net KRW8.108T Vs. Net KRW1.917T >000660.SE

23 Apr 2025, 22:49 UTC

Earnings

SK Hynix 1Q Oper Pft KRW7.441T Vs. Pft KRW2.886T >000660.SE

23 Apr 2025, 22:49 UTC

Earnings

SK Hynix 1Q Rev KRW17.639T Vs. KRW12.430T >000660.SE

23 Apr 2025, 22:32 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Global Energy Roundup: Market Talk

23 Apr 2025, 22:32 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Woodside Appears Cornered Into 2Q Decision on Louisiana LNG -- Market Talk

23 Apr 2025, 22:29 UTC

Market Talk
Earnings

ServiceNow CEO Says Aptiv Deal Marks 2nd Largest in EMEA -- Market Talk

23 Apr 2025, 22:18 UTC

Earnings

CGN Power: 1Q Net Weighed by Fall in Electricity Prices, Higher R&D Expenses >1816.HK

23 Apr 2025, 22:17 UTC

Earnings

CGN Power 1Q Net CNY3.03B Vs. Net CNY3.60B >1816.HK

23 Apr 2025, 22:17 UTC

Earnings

CGN Power 1Q Rev CNY20.03B Vs. CNY19.18B >1816.HK

23 Apr 2025, 21:57 UTC

Market Talk
Earnings

ServiceNow Earnings, Guidance Soothe Fear of Slower Govt Business -- Market Talk

23 Apr 2025, 21:48 UTC

Top News

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 Apr 2025, 21:14 UTC

Top News
Earnings

Southwest Airlines Drops Forecast as Leisure Travelers Pull Back -- WSJ

23 Apr 2025, 21:05 UTC

Earnings

Texas Instruments Reports Strong Earnings. The Stock Is Rising but Tariffs Are Still a Risk. -- Barrons.com

23 Apr 2025, 21:02 UTC

Top News

Huge Stock Swings Are the New Normal for Frazzled Investors -- WSJ

23 Apr 2025, 20:51 UTC

Earnings

Boeing Stock Surges on Earnings. There Is Still a Lot of Uncertainty Ahead. -- Barrons.com

23 Apr 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

23 Apr 2025, 20:47 UTC

Top News

Shingles Vaccine Appears to Lower Dementia Risk -- WSJ

23 Apr 2025, 20:46 UTC

Acquisitions, Mergers, Takeovers

Newmont CEO Tom Palmer Comments During Conference Call With Reporters

23 Apr 2025, 20:46 UTC

Acquisitions, Mergers, Takeovers

Newmont CEO: Tariffs Have Added a New Driver for Price of Gold

Peer Comparison

Price change

Kala Pharmaceuticals Inc Forecast

Price Target

By TipRanks

410.2% upside

12 Months Forecast

Average 15 USD  410.2%

High 15 USD

Low 15 USD

Based on 2 Wall Street analysts offering 12 month price targets forKala Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Financials

$

About Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc